Golgi Cells, named after Camillo Golgi, the Italian neuroscientist who discovered them, are specialized inhibitory interneurons primarily found in the granular layer of the cerebellum, a region crucial for motor coordination and control. These small, stellate-shaped cells play a pivotal role in regulating information flow within the cerebellar circuitry. Golgi cells receive inputs from mossy fibers, which convey sensory and motor information, and exert inhibitory control over granule cells through the release of neurotransmitters like gamma-aminobutyric acid (GABA). By fine-tuning the activity of granule cells, Golgi cells contribute to the precise modulation of cerebellar output. This regulation is essential for coordinating voluntary movements, maintaining balance, and adapting motor responses. Dysfunction in Golgi cells is implicated in cerebellar disorders and ataxias. Research on Golgi cells contributes to our understanding of cerebellar function and its role in motor learning and coordination. Investigating the complex interplay between different cell types within the cerebellum, including Golgi cells, provides insights into the neural mechanisms underlying motor control and coordination. The study of Golgi cells continues to be an active area of research, offering potential avenues for therapeutic interventions in neurological conditions affecting motor function.
Title : AI-integrated high-throughput tissue-chip for space-based biomanufacturing applications
Kunal Mitra, Florida Tech, United States
Title : Stem cell technologies to integrate biodesign related tissue engineering within the frame of cell based regenerative medicine: towards the preventive therapeutic and rehabilitative resources and benefits
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : In vitro evaluation of lyophilized Dedifferentiated Fat cells (DFAT) impregnated artificial dermis
Kazutaka Soejima, Nihon University, School of Medicine, Japan
Title :
Nagy Habib, Imperial College London, United Kingdom
Title :
Alexander Seifalian, Nanotechnology & Regenerative Medicine Commercialisation Centre, United Kingdom
Title : The regenerative medicine of the future
Marco Polettini, DVM, Italy